Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
In the latest session, Inspire Medical Systems Inc (NYSE: INSP) closed at $162.53 down -5.95% from its previous closing price of $172.82. In other words, the price has decreased by -$5.95 from its previous closing price. On the day, 0.6 million shares were traded. INSP stock price reached its highest trading level at $174.99 during the session, while it also had its lowest trading level at $162.53.
Ratios:
For a deeper understanding of Inspire Medical Systems Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 10.82 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 52.92. For the most recent quarter (mrq), Quick Ratio is recorded 6.22 and its Current Ratio is at 7.13. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.04.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on November 20, 2024, Upgraded its rating to Buy and sets its target price to $255 from $220 previously.
On May 08, 2024, BofA Securities Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $265 to $225.
On April 19, 2024, RBC Capital Mkts started tracking the stock assigning a Outperform rating and target price of $285.RBC Capital Mkts initiated its Outperform rating on April 19, 2024, with a $285 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 03 ’25 when Ban Randy sold 3,947 shares for $185.84 per share. The transaction valued at 733,496 led to the insider holds 7,259 shares of the business.
Rondoni John sold 2,287 shares of INSP for $424,467 on Mar 03 ’25. The Chief Technology Officer now owns 15,500 shares after completing the transaction at $185.60 per share. On Mar 03 ’25, another insider, JOHN RONDONI, who serves as the Officer of the company, bought 2,287 shares for $185.60 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INSP now has a Market Capitalization of 4822167552 and an Enterprise Value of 4408415744. As of this moment, Inspire’s Price-to-Earnings (P/E) ratio for their current fiscal year is 93.76, and their Forward P/E ratio for the next fiscal year is 50.86. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.69. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.01 while its Price-to-Book (P/B) ratio in mrq is 7.01. Its current Enterprise Value per Revenue stands at 5.491 whereas that against EBITDA is 103.404.
Stock Price History:
The Beta on a monthly basis for INSP is 1.35, which has changed by -0.15357774 over the last 52 weeks, in comparison to a change of 0.087141395 over the same period for the S&P500. Over the past 52 weeks, INSP has reached a high of $257.40, while it has fallen to a 52-week low of $123.00. The 50-Day Moving Average of the stock is -12.58%, while the 200-Day Moving Average is calculated to be -10.09%.
Shares Statistics:
For the past three months, INSP has traded an average of 565.12K shares per day and 486430 over the past ten days. A total of 29.74M shares are outstanding, with a floating share count of 28.24M. Insiders hold about 4.81% of the company’s shares, while institutions hold 110.04% stake in the company. Shares short for INSP as of 1740700800 were 3137819 with a Short Ratio of 5.55, compared to 1738281600 on 2520469. Therefore, it implies a Short% of Shares Outstanding of 3137819 and a Short% of Float of 12.16.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
